American Century Companies’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.3K Sell
18,381
-500
-3% -$1.21K ﹤0.01% 2873
2026
Q1
$44.4K Hold
18,881
﹤0.01% 2814
2025
Q4
$45.1K Hold
18,881
﹤0.01% 2797
2025
Q3
$50.2K Sell
18,881
-6,995
-27% -$20.7K ﹤0.01% 2773
2025
Q2
$76.9K Sell
25,876
-75,782
-75% -$220K ﹤0.01% 2809
2025
Q1
$329K Sell
101,658
-22,587
-18% -$77.9K ﹤0.01% 2643
2024
Q4
$491K Sell
124,245
-5,938
-5% -$40.5K ﹤0.01% 2511
2024
Q3
$1.01M Buy
130,183
+53,723
+70% +$353K ﹤0.01% 2231
2024
Q2
$393K Buy
+76,460
New +$590K ﹤0.01% 2524

Other funds holding XBIT

American Century Companies's XBIT Position: Q2 2026 in Review

American Century Companies reduced its XBiotech (XBIT) stake by 2.6% in Q2 2026, selling an estimated $1.21K and leaving 18,381 shares worth $42.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2873.

American Century Companies first reported a position in XBIT in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.01M in Q3 2024. 36 funds tracked by Wall St. Rank hold XBIT as of Q2 2026.

  • American Century Companies held 18,381 shares of XBiotech worth $42.3K as of Q2 2026.
  • American Century Companies sold 500 XBiotech shares in Q2 2026, an estimated $1.21K.
  • XBiotech made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2873 holding.
  • American Century Companies first reported a position in XBiotech in Q2 2024 and has held it in 9 quarters since.
  • American Century Companies's XBiotech position peaked at $1.01M in Q3 2024.
  • 36 funds tracked by Wall St. Rank held XBiotech as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.